The medical technology industry is highly competitive and continues to evolve, with success measured by the development of innovative products and the value brought to stakeholders. We are committed to developing new technologies and providing innovative patient care. Our investments in research and development, which amounted to 17.3% of net sales in 2020, reflect our focus on enhancing our capabilities in response to changing business needs and directions. The COVID-19 pandemic has impacted nearly all aspects of our business, requiring us to adapt our operations and manage inventory proactively while assessing alternative logistics options. Our manufacturing operations have continued to respond to these impacts, ensuring continuous access to our life-saving technologies. The ability to provide data and information to users with appropriate levels of accuracy, timeliness, reliability, security, confidentiality, connectivity, and access is critical to our information management capability. We have been able to leverage our IT resources effectively to support business needs and enhance operational efficiency. The ongoing adoption of our products, such as the Edwards Sapien 3 Ultra system, demonstrates our capability to transform a firm into a competitive force. Our sales growth in transcatheter aortic valve replacement products was driven by regulatory approvals and positive market response, despite challenges posed by the pandemic. The demand for our pressure monitoring products increased in critical care settings, showcasing our ability to respond to market dynamics and external influences. Our strategic resource allocation decisions, including investments in transcatheter mitral and tricuspid therapies, are aimed at enhancing our organizational capabilities and ensuring we meet the evolving needs of our customers. We are dedicated to generating robust clinical, economic, and quality of life evidence, which is increasingly expected by patients, clinicians, and payors. This commitment underscores our focus on innovation partnerships and the strategic management of our technology portfolio. Our operational flexibility and ability to mobilize IT-based resources in combination with other capabilities are essential for maintaining our competitive advantage. The challenges associated with the pandemic have highlighted the importance of our IT governance and the need for effective management skills to navigate the evolving healthcare environment. We continue to monitor the performance impacts of our strategic decisions and the effectiveness of our IT systems to ensure alignment with our organizational goals. Our focus on business process management and the optimization of internal processes is critical for enhancing our overall performance and achieving our long-term objectives. The integration of digital technologies into our operations is a key factor in driving business transformation and improving our market agility. As we look to the future, we remain committed to leveraging our IT capabilities to support our strategic initiatives and enhance our organizational effectiveness in a rapidly changing business landscape.